Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo

Immunology

Volumn 143, Issue 2, 2014, Pages 155-163

  Rönnberg, Elin ^a   Johnzon, Carl Fredrik ^a   Calounova, Gabriela ^a   Garcia Faroldi, Gianni ^a   Grujic, Mirjana ^a   Hartmann, Karin ^b   Roers, Axel ^c   Guss, Bengt ^a   Lundequist, Anders ^a   Pejler, Gunnar ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Bacterial infection; Inflammation; Mast cells; Staphylococcus aureus

Indexed keywords

AUTACOID; CYTOKINE;

ANIMAL; ARTICLE; BACTERIAL INFECTION; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLAMMATION; MAST CELL; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PERITONITIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSGENIC MOUSE;

BACTERIAL INFECTION; INFLAMMATION; MAST CELLS; STAPHYLOCOCCUS AUREUS;

ANIMALS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; INFLAMMATION MEDIATORS; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84908158081     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12297     Document Type: Article

References (28)

1. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010; 10:440-52.
2. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
3. Wertheim HF, Vos MC, Ott A et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364:703-5.
4. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
5. Abel J, Goldmann O, Ziegler C et al. Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake. J Innate Immun 2011; 3:495-507.
6. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor α release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008; 76:4489-97.
7. Malbec O, Roget K, Schiffer C, Iannascoli B, Dumas AR, Arock M, Daeron M. Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells. J Immunol 2007; 178:6465-75.
8. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381:75-7.
9. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996; 381:77-80.
10. Xu X, Zhang D, Lyubynska N et al. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 2006; 173:219-25.
11. Malaviya R, Ikeda T, Abraham SN. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol Lett 2004; 91:103-11.
12. Wei OL, Hilliard A, Kalman D, Sherman M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect Immun 2005; 73:1978-85.
13. Siebenhaar F, Syska W, Weller K, Magerl M, Zuberbier T, Metz M, Maurer M. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol 2007; 170:1910-6.
14. W-sh/W-sh mice. Am J Pathol 2010; 176:926-38.
15. Thakurdas SM, Melicoff E, Sansores-Garcia L, Moreira DC, Petrova Y, Stevens RL, Adachi R. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem 2007; 282:20809-15.
16. Reber LL, Marichal T, Galli SJ. New models for analyzing mast cell functions in vivo. Trends Immunol 2012; 33:613-25.
17. Rodewald HR, Feyerabend TB. Widespread immunological functions of mast cells: fact or fiction? Immunity 2012; 37:13-24.
18. Dudeck A, Dudeck J, Scholten J et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011; 34:973-84.
19. Sjostrom JE, Lofdahl S, Philipson L. Transformation reveals a chromosomal locus of the gene(s) for methicillin resistance in Staphylococcus aureus. J Bacteriol 1975; 123:905-15.
20. Ronnberg E, Guss B, Pejler G. Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response. Infect Immun 2010; 78:854-64.
21. Ma YJ, Kim CH, Ryu KH, Kim MS, So YI, Lee KJ, Garred P, Lee BL. Adenosine derived from Staphylococcus aureus-engulfed macrophages functions as a potent stimulant for the induction of inflammatory cytokines in mast cells. BMB Rep 2011; 44:335-40.
22. Lundequist A, Calounova G, Wensman H, Ronnberg E, Pejler G. Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation. Mol Immunol 2011; 48:1753-61.
23. Garcia-Faroldi G, Ronnberg E, Orro A, Calounova G, Guss B, Lundequist A, Pejler G. ADAMTS: novel proteases expressed by activated mast cells. Biol Chem 2012; 394:291-305.
24. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005; 167:835-48.
25. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8:1095-104.
26. Feyerabend TB, Weiser A, Tietz A et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011; 35:832-44.
27. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297:1689-92.
28. Secor VH, Secor WE, Gutekunst CA, Brown MA. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000; 191:813-22.